These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32936321)

  • 41. Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit.
    Chaperon F; Müller W; Auberson YP; Tricklebank MD; Neijt HC
    Behav Pharmacol; 2003 Sep; 14(5-6):477-87. PubMed ID: 14501261
    [TBL] [Abstract][Full Text] [Related]  

  • 42. State-dependent NMDA receptor antagonism by Ro 8-4304, a novel NR2B selective, non-competitive, voltage-independent antagonist.
    Kew JN; Trube G; Kemp JA
    Br J Pharmacol; 1998 Feb; 123(3):463-72. PubMed ID: 9504387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of noradrenergic and serotonergic systems in risk-based decisions between options of equivalent expected value in rats.
    Cui RS; Ruan H; Liu LY; Li XW
    Neurobiol Learn Mem; 2020 Nov; 175():107310. PubMed ID: 32890758
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of the competitive N-methyl-D-aspartate receptor antagonist, LY235959 [(-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid], on responding for cocaine under both fixed and progressive ratio schedules of reinforcement.
    Allen RM; Carelli RM; Dykstra LA; Suchey TL; Everett CV
    J Pharmacol Exp Ther; 2005 Oct; 315(1):449-57. PubMed ID: 16024734
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dopamine receptors regulate preference between high-effort and high-risk rewards.
    Gabriel DBK; Liley AE; Freels TG; Simon NW
    Psychopharmacology (Berl); 2021 Apr; 238(4):991-1004. PubMed ID: 33410986
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An examination of NMDA receptor contribution to conditioned responding evoked by the conditional stimulus effects of nicotine.
    Murray JE; Walker AW; Polewan RJ; Bevins RA
    Psychopharmacology (Berl); 2011 Jan; 213(1):131-41. PubMed ID: 20859617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NMDA receptor subunits and associated signaling molecules mediating antidepressant-related effects of NMDA-GluN2B antagonism.
    Kiselycznyk C; Jury NJ; Halladay LR; Nakazawa K; Mishina M; Sprengel R; Grant SG; Svenningsson P; Holmes A
    Behav Brain Res; 2015; 287():89-95. PubMed ID: 25800971
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NMDA Receptor GluN2 Subtypes Control Epileptiform Events in the Hippocampus.
    Punnakkal P; Dominic D
    Neuromolecular Med; 2018 Mar; 20(1):90-96. PubMed ID: 29335819
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Examining the neurochemical underpinnings of animal models of risky choice: Methodological and analytic considerations.
    Yates JR
    Exp Clin Psychopharmacol; 2019 Apr; 27(2):178-201. PubMed ID: 30570275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Memory in aged mice is rescued by enhanced expression of the GluN2B subunit of the NMDA receptor.
    Brim BL; Haskell R; Awedikian R; Ellinwood NM; Jin L; Kumar A; Foster TC; Magnusson KR
    Behav Brain Res; 2013 Feb; 238():211-26. PubMed ID: 23103326
    [TBL] [Abstract][Full Text] [Related]  

  • 51. N-Methyl-D-aspartate receptor antagonists and the development of tolerance to the discriminative stimulus effects of morphine in rats.
    Bespalov AY; Balster RL; Beardsley PM
    J Pharmacol Exp Ther; 1999 Jul; 290(1):20-7. PubMed ID: 10381755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery of (R)-1-[2-hydroxy-3-(4-hydroxy-phenyl)-propyl]-4-(4-methyl-benzyl)-piperidin-4-ol: a novel NR1/2B subtype selective NMDA receptor antagonist.
    Pinard E; Alanine A; Bourson A; Büttelmann B; Gill R; Heitz M; Jaeschke G; Mutel V; Trube G; Wyler R
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2173-6. PubMed ID: 11514163
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protective use of N-methyl-D-aspartate receptor antagonists as a spinoplegia against excitatory amino acid neurotoxicity.
    Cho Y; Ueda T; Mori A; Shimizu H; Haga Y; Yozu R
    J Vasc Surg; 2005 Oct; 42(4):765-71. PubMed ID: 16242566
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risky decision-making predicts dopamine release dynamics in nucleus accumbens shell.
    Freels TG; Gabriel DBK; Lester DB; Simon NW
    Neuropsychopharmacology; 2020 Jan; 45(2):266-275. PubMed ID: 31546248
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perturbations in different forms of cost/benefit decision making induced by repeated amphetamine exposure.
    Floresco SB; Whelan JM
    Psychopharmacology (Berl); 2009 Aug; 205(2):189-201. PubMed ID: 19365622
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of GluN2A and GluN2B subunits on the effects of NMDA receptor antagonists in modeling schizophrenia and treating refractory depression.
    Jiménez-Sánchez L; Campa L; Auberson YP; Adell A
    Neuropsychopharmacology; 2014 Oct; 39(11):2673-80. PubMed ID: 24871546
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Roles of NMDA and dopamine in food-foraging decision-making strategies of rats in the social setting.
    Li F; Cao WY; Huang FL; Kang WJ; Zhong XL; Hu ZL; Wang HT; Zhang J; Zhang JY; Dai RP; Zhou XF; Li CQ
    BMC Neurosci; 2016 Jan; 17():3. PubMed ID: 26754043
    [TBL] [Abstract][Full Text] [Related]  

  • 58. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Huang KX; Bergstrom DA; Ruskin DN; Walters JR
    Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease.
    Löschmann PA; Wüllner U; Heneka MT; Schulz JB; Kunow M; Wachtel H; Klockgether T
    Synapse; 1997 Aug; 26(4):381-91. PubMed ID: 9215597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MeCP2 Expression in a Rat Model of Risky Decision Making.
    Deng JV; Orsini CA; Shimp KG; Setlow B
    Neuroscience; 2018 Jan; 369():212-221. PubMed ID: 29155278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.